Cavalli F - Search Results

1

Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer.

Rozencweig M, ten Bokkel Huinink W, Cavalli F, Bruntsch U, Dombernowsky P, Høst H, Bramwell V, Renard G, Van Glabbeke M, Decoster G. Rozencweig M, et al. Among authors: cavalli f. J Clin Oncol. 1984 Apr;2(4):275-81. doi: 10.1200/JCO.1984.2.4.275. J Clin Oncol. 1984. PMID: 6584561 Clinical Trial.

2

TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials Group.

Gundersen S, Dombernowsky P, Cavalli F, Bruntsch U, Renard J, Van Glabbeke M, Pinedo H. Gundersen S, et al. Among authors: cavalli f. Eur J Cancer Clin Oncol. 1989 Jul;25(7):1095-7. doi: 10.1016/0277-5379(89)90394-5. Eur J Cancer Clin Oncol. 1989. PMID: 2759163

3

Phase II study of iproplatin in advanced ovarian carcinoma.

Sessa C, Vermorken J, Renard J, Kaye S, Smith D, ten Bokkel Huinink W, Cavalli F, Pinedo H. Sessa C, et al. Among authors: cavalli f. J Clin Oncol. 1988 Jan;6(1):98-105. doi: 10.1200/JCO.1988.6.1.98. J Clin Oncol. 1988. PMID: 3335895

4

Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).

Holdener EE, Hansen HH, Høst H, Bruntsch U, Cavalli F, Renard J, Pinedo HM, Rozencweig M. Holdener EE, et al. Among authors: cavalli f. Invest New Drugs. 1985;3(1):63-6. doi: 10.1007/BF00176826. Invest New Drugs. 1985. PMID: 3857219

5

Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.

Høst H, Joss R, Pinedo H, Bruntsch U, Cavalli F, Renard G, van Glabbeke M, Rozencweig M. Høst H, et al. Among authors: cavalli f. Eur J Cancer Clin Oncol. 1983 Feb;19(2):295-8. doi: 10.1016/0277-5379(83)90430-3. Eur J Cancer Clin Oncol. 1983. PMID: 6681775

6

Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group.

De Jager R, Siegenthaler P, Cavalli F, Klepp O, Bramwell V, Joss R, Alberto P, van Glabbeke M, Renard J, Rozencweig M, Hansen HH. De Jager R, et al. Among authors: cavalli f. Eur J Cancer Clin Oncol. 1983 Feb;19(2):289-93. doi: 10.1016/0277-5379(83)90429-7. Eur J Cancer Clin Oncol. 1983. PMID: 6687457

7

Phase II study of intravenous menogaril in patients with advanced breast cancer.

Sessa C, Gundersen S, ten Bokkel Huinink W, Renard J, Cavalli F. Sessa C, et al. Among authors: cavalli f. J Natl Cancer Inst. 1988 Sep 7;80(13):1066-9. doi: 10.1093/jnci/80.13.1066. J Natl Cancer Inst. 1988. PMID: 2970554

8

"Design of phase I and II clinical trials in cancer: a statistician's view.".

Decoster G, Cavalli F. Decoster G, et al. Among authors: cavalli f. Cancer Invest. 1987;5(6):649-50. doi: 10.3109/07357908709020324. Cancer Invest. 1987. PMID: 3442736 No abstract available.

9

Phase II trial of triglycidylurazol (TGU) in advanced malignant melanoma.

Gundersen S, Abele R, Cavalli F, Clavel M, Dodion P, Renard G, van Glabbeke M. Gundersen S, et al. Among authors: cavalli f. Eur J Cancer Clin Oncol. 1987 Feb;23(2):251-2. doi: 10.1016/0277-5379(87)90022-8. Eur J Cancer Clin Oncol. 1987. PMID: 3443138 No abstract available.

10

Phase II evaluation of bisantrene in metastatic breast cancer.

Cavalli F, Gerard B, ten Bokkel Huinink W, Clavel M, Rozencweig M. Cavalli F, et al. Cancer Treat Rep. 1985 Mar;69(3):337-8. Cancer Treat Rep. 1985. PMID: 3978661 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

642 results

Search Page

Filters